Erratum to: A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease

Catarina Godinho^{1

2

3}, Josefa Domingos^{1

3}, Guilherme Cunha⁴, Ana T Santos¹, Ricardo M Fernandes^{1

4}, Daisy Abreu¹, Nilza Gonçalves¹, Helen Matthews⁵, Tom Isaacs⁵, Joy Duffen⁵, Ahmed Al-Jawad⁶, Frank Larsen⁷, Artur Serrano⁷, Peter Weber⁸, Andrea Thoms⁸, Stefan Sollinger⁹, Holm Graessner¹⁰, Walter Maetzler¹¹, Joaquim J Ferreira^{12

13

14}

Affiliations

¹ Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.
² Instituto Superior de Ciências da Saúde Egas Moniz, Center for Interdisciplinary Research Egas Moniz (CiiEM), Monte de Caparica, Portugal.
³ CNS-Campus Neurológico Sénior, Torres Vedras, Portugal.
⁴ Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
⁵ The Cure Parkinson's Trust, London, UK.
⁶ HSG-IMIT, Villingen-Schwenningen, Germany.
⁷ Norwegian Centre for Telemedicine, Tromso, Norway.
⁸ Hasomed GmbH, Magdeburg, Germany.
⁹ AbilityNet, London, UK.
¹⁰ Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
¹¹ Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany.
¹² Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. joaquimjferreira@gmail.com.
¹³ Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. joaquimjferreira@gmail.com.
¹⁴ CNS-Campus Neurológico Sénior, Torres Vedras, Portugal. joaquimjferreira@gmail.com.

Published Erratum

Catarina Godinho et al. J Neuroeng Rehabil. 2016.

. 2016 Aug 1;13(1):71.

doi: 10.1186/s12984-016-0181-2.

¹ Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.
² Instituto Superior de Ciências da Saúde Egas Moniz, Center for Interdisciplinary Research Egas Moniz (CiiEM), Monte de Caparica, Portugal.
³ CNS-Campus Neurológico Sénior, Torres Vedras, Portugal.
⁴ Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
⁵ The Cure Parkinson's Trust, London, UK.
⁶ HSG-IMIT, Villingen-Schwenningen, Germany.
⁷ Norwegian Centre for Telemedicine, Tromso, Norway.
⁸ Hasomed GmbH, Magdeburg, Germany.
⁹ AbilityNet, London, UK.
¹⁰ Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
¹¹ Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany.
¹² Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. joaquimjferreira@gmail.com.
¹³ Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. joaquimjferreira@gmail.com.
¹⁴ CNS-Campus Neurológico Sénior, Torres Vedras, Portugal. joaquimjferreira@gmail.com.

No abstract available

Erratum for

A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease.
Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, Gonçalves N, Matthews H, Isaacs T, Duffen J, Al-Jawad A, Larsen F, Serrano A, Weber P, Thoms A, Sollinger S, Graessner H, Maetzler W, Ferreira JJ. Godinho C, et al. J Neuroeng Rehabil. 2016 Mar 12;13:24. doi: 10.1186/s12984-016-0136-7. J Neuroeng Rehabil. 2016. PMID: 26969628 Free PMC article.

1. Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D et al. A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease. J Neuroeng Rehabil. 2015;13(24). doi:10.1186/s12984-016-0136-7 - PMC - PubMed